Literature DB >> 30159407

Non-coding RNAs: A tale of junk turning into treasure.

Aamir Ahmad1.   

Abstract

Entities:  

Year:  2017        PMID: 30159407      PMCID: PMC6096404          DOI: 10.1016/j.ncrna.2016.12.001

Source DB:  PubMed          Journal:  Noncoding RNA Res        ISSN: 2468-0540


× No keyword cloud information.

Editorial perspective

Biochemists and molecular biologists, who have been in the field for a couple of decades, would probably remember the time when it was a norm to term all RNA ‘junk’ if it did not translate into a protein product. Gone are those days. The erstwhile ‘junk’ RNA is now a much pursued and sought entity. The RNA molecules that do not code for any proteins; the ‘non-coding RNAs’, are now a hot topic in modern day research. Many non-coding RNAs are very much functional in biological systems, and compensate for their inability to be translated into proteins through alternate mechanisms. As it turns out, the non-coding RNAs are quite abundant [1]. The sequencing of human genome at the turn of century, followed by recent advancements in the technical capabilities have resulted in a much better understanding of transcriptional landscape i.e. the fate of a majority of RNAs that are transcribed from human genome [2]. It is believed that three quarters of human genome is capable of being transcribed, which, simply speaking, is a lot of RNA. Only a tiny fraction (3%) of the genome consists of protein-coding genes [3] which means that a vast majority of genome gets transcribed into non-coding RNAs. While our knowledge on the subject is far from complete, by all estimates it can be concluded that the number of non-coding RNAs is much more than the ‘coding RNAs’ that get translated into proteins [3], [4]. This immediately raises a red flag – after all, why these seemingly useless genome portions, that produce numerous non-coding RNA transcripts, have not been lost during the course of evolution. A logical explanation would be that these RNA transcripts are not useless after all. They have definite functionality. It can even be envisioned that the complexity of life, and the intricate regulation of cellular processes, better correlates with the repertoire and diversity of non-coding RNAs, as opposed to the coding-RNAs [4], [5]. Research efforts over last several years have established an ever-increasing importance of non-coding RNAs in many human health conditions [6], [7]. Not all non-coding RNAs are alike. There are several different subtypes - microRNAs (miRNAs), small interfering RNAs (siRNAs), small nucleolar RNAs (snoRNAs), U-RNAs/small nuclear RNAs (snRNAs), exosomal/extracellular RNAs (exRNAs), Piwi-interacting RNAs (piRNAs) and long non-coding RNAs. Of course, a few have been investigated more than the others. miRNAs have attracted enormous interest in recent years, so much so that it is hard to consider them as a subtype of non-coding RNAs. The published work on miRNAs is many folds higher than all the other non-coding RNAs combined [8]. The other non-coding RNA that has been investigated in sufficient detail is the long non-coding RNA [1], [4], [8]. The importance of non-coding RNAs is also not limited to just one human condition/disease. Accumulating literature suggests that these RNAs are relevant to aging [9], cancer [10], [11], [12], cardiovascular diseases [12], diabetes and related complications [13], [14], [15], endocrine system [16], immune system [17], kidney diseases [18], obesity [19], neurodevelopment [20], [21] – pretty much everything. Non-coding RNAs are a subject of research investigations into origin of individual diseases, with differential expression of select non-coding RNAs being tied to disease onset [6], [22]. They are also being evaluated for their putative role in disease diagnosis as a biomarker [23], [24] as well as in prognosis and predictor of response to therapy [24], [25]. It is not surprising, therefore, that many non-coding RNAs are being tested for their possible use in therapy of individual diseases [8], [26], [27], [28]. With such a high level of interest in the role of non-coding RNAs in human health and diseases, it is about time that a platform dedicated to the comprehensive exchange of information on non-coding RNAs is established. The journal “Non-coding RNA Research” is an effort in this direction. The primary aim of this interdisciplinary journal is to disseminate cutting edge research focused on non-coding RNAs in modern day research and medicine. Without setting any boundaries, with regards to specific diseases or the precise nature of non-coding RNA-mediated regulation, this journal will welcome all rigorously performed primary research and clinical studies as well as timely reviews focusing on virtually all aspects of non-coding RNAs – their biogenesis, inter-regulation(s) and functional role in human diseases. This first issue very well represents the non-coding RNAs' diverse functional role, with articles on very distinct topics. Even with all the published literature on non-coding RNAs, it is safe to conclude that this research area is still in its infancy and we have barely scratched the surface. The ‘seemingly’ inconsequential non-coding RNA molecules definitely hold a lot of promise, and it will be this journal's endeavor to publish articles that showcase the ever-evolving importance of non-coding RNAs.
  28 in total

Review 1.  Unique features of long non-coding RNA biogenesis and function.

Authors:  Jeffrey J Quinn; Howard Y Chang
Journal:  Nat Rev Genet       Date:  2016-01       Impact factor: 53.242

Review 2.  Non-coding RNAs in homeostasis, disease and stress responses: an evolutionary perspective.

Authors:  Paulo P Amaral; Marcel E Dinger; John S Mattick
Journal:  Brief Funct Genomics       Date:  2013-05       Impact factor: 4.241

Review 3.  Non-coding RNAs: regulators of disease.

Authors:  Ryan J Taft; Ken C Pang; Timothy R Mercer; Marcel Dinger; John S Mattick
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

4.  Long noncoding RNAs in diabetic retinopathy.

Authors:  Nicolas Jaé; Stefanie Dimmeler
Journal:  Circ Res       Date:  2015-03-27       Impact factor: 17.367

Review 5.  Noncoding RNAs in the development, diagnosis, and prognosis of colorectal cancer.

Authors:  Mingjiao Weng; Di Wu; Chao Yang; Haisheng Peng; Guangyu Wang; Tianzhen Wang; Xiaobo Li
Journal:  Transl Res       Date:  2016-10-14       Impact factor: 7.012

Review 6.  Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Nat Rev Neurosci       Date:  2012-07-20       Impact factor: 34.870

Review 7.  Long noncoding RNAs: past, present, and future.

Authors:  Johnny T Y Kung; David Colognori; Jeannie T Lee
Journal:  Genetics       Date:  2013-03       Impact factor: 4.562

Review 8.  MicroRNA regulatory networks in human adipose tissue and obesity.

Authors:  Peter Arner; Agné Kulyté
Journal:  Nat Rev Endocrinol       Date:  2015-03-03       Impact factor: 43.330

Review 9.  Long Noncoding RNAs in Cancer Pathways.

Authors:  Adam M Schmitt; Howard Y Chang
Journal:  Cancer Cell       Date:  2016-04-11       Impact factor: 31.743

10.  Genome-wide Long Non-coding RNA Analysis Identified Circulating LncRNAs as Novel Non-invasive Diagnostic Biomarkers for Gynecological Disease.

Authors:  Wen-Tao Wang; Yu-Meng Sun; Wei Huang; Bo He; Ya-Nan Zhao; Yue-Qin Chen
Journal:  Sci Rep       Date:  2016-03-18       Impact factor: 4.379

View more
  14 in total

Review 1.  Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours.

Authors:  Kristian Almstrup; João Lobo; Nina Mørup; Gazanfer Belge; Ewa Rajpert-De Meyts; Leendert H J Looijenga; Klaus-Peter Dieckmann
Journal:  Nat Rev Urol       Date:  2020-03-10       Impact factor: 14.432

Review 2.  Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.

Authors:  Mohammad Aslam Aslam Khan; Shafquat Azim; Haseeb Zubair; Arun Bhardwaj; Girijesh Kumar Patel; Moh'd Khushman; Seema Singh; Ajay Pratap Singh
Journal:  Int J Mol Sci       Date:  2017-04-06       Impact factor: 5.923

Review 3.  Exosomes: Emerging Diagnostic and Therapeutic Targets in Cutaneous Diseases.

Authors:  Abdul Q Khan; Sabah Akhtar; Kirti S Prabhu; Lubna Zarif; Rehan Khan; Majid Alam; Joerg Buddenkotte; Aamir Ahmad; Martin Steinhoff; Shahab Uddin
Journal:  Int J Mol Sci       Date:  2020-12-04       Impact factor: 5.923

Review 4.  Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19.

Authors:  Shama Ahmad; Shajer Manzoor; Simmone Siddiqui; Nithya Mariappan; Iram Zafar; Aamir Ahmad; Aftab Ahmad
Journal:  Semin Cancer Biol       Date:  2021-01-20       Impact factor: 17.012

5.  What is beyond LncRNAs in breast cancer: A special focus on colon cancer-associated Transcript-1 (CCAT-1).

Authors:  Noha A Selem; Rana A Youness; Mohamed Z Gad
Journal:  Noncoding RNA Res       Date:  2021-12-01

6.  microRNAs in cancer chemoresistance: The sword and the shield.

Authors:  Priya Mondal; Syed Musthapa Meeran
Journal:  Noncoding RNA Res       Date:  2021-12-09

7.  Long Non-coding RNA Signature for Liver Metastasis of Colorectal Cancers.

Authors:  Fang Liu; Zhen-Mei Song; Xiao-Di Wang; Shi-Yu Du; Na Peng; Jing-Rui Zhou; Ming-Gang Zhang
Journal:  Front Cell Dev Biol       Date:  2021-07-08

8.  lncRNA Signature for Predicting Cerebral Vasospasm in Patients with SAH: Implications for Precision Neurosurgery.

Authors:  Chen-Yu Pan; Miao Tian; Lei-Lei Zhang; Dan Tian; Li-Yan Wang; Yu-Jia Sun; Yun-Feng Cui
Journal:  Mol Ther Nucleic Acids       Date:  2020-07-25       Impact factor: 8.886

9.  Editorial: LncRNAs in Cancer Metastasis and Therapy Resistance.

Authors:  Aamir Ahmad; Palmiro Poltronieri; Shahab Uddin
Journal:  Front Oncol       Date:  2021-12-10       Impact factor: 6.244

10.  Exosomal miR-2276-5p in Plasma Is a Potential Diagnostic and Prognostic Biomarker in Glioma.

Authors:  Jingxian Sun; Zhenying Sun; Ilgiz Gareev; Tao Yan; Xin Chen; Aamir Ahmad; Daming Zhang; Boxian Zhao; Ozal Beylerli; Guang Yang; Shiguang Zhao
Journal:  Front Cell Dev Biol       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.